Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,931,098
+$174,383 QoQ
Shares Held
15,028
+2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,607
of 3,769 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KEYNOTE FINANCIAL SERVICES LLC holds $25,265,456 across 9 Drug Manufacturers - General names. MRK ranks #7 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
38,262 | $9,628,249 | |
| 2 | JNJ |
Johnson & Johnson
|
11,963 | $3,038,243 | |
| 3 | LLY |
ELI LILLY & Co
|
2,030 | $2,434,843 | |
| 4 | PFE |
Pfizer Inc
|
94,489 | $2,275,295 | |
| 5 | AMGN |
Amgen Inc
|
6,280 | $2,274,113 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
33,564 | $1,933,957 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
15,028 | $1,931,098 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,178 | $1,538,568 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,931,098 | 15,028 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,756,715 | 14,604 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,540,901 | 14,639 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,223,951 | 14,583 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,131,988 | 14,300 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,075,953 | 11,987 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $842,197 | 8,466 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $707,933 | 6,234 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $771,769 | 6,234 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $822,576 | 6,234 | Shares | Sole | 2024-06-13 | |
| No filing history on record for this holder in this stock. | ||||||